Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the efficacy and safety of exemestane as a treatment for estrogen-receptor-positive breast cancer and reports no new clinical results.

In this case report, hyperandrogenism, including hirsutism and elevated testosterone, in a post-menopausal woman on anastrozole for breast cancer may be attributed to the drug after ruling out other serious causes like ovarian hyperthecosis.

Hair loss is a common side effect of hormone treatments for cancer.